327 related articles for article (PubMed ID: 21701688)
1. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo.
Lee ZW; Zhou J; Chen CS; Zhao Y; Tan CH; Li L; Moore PK; Deng LW
PLoS One; 2011; 6(6):e21077. PubMed ID: 21701688
[TBL] [Abstract][Full Text] [Related]
2. Effects of fast versus slow-releasing hydrogen sulfide donors in hypertension in pregnancy and fetoplacental growth restriction.
Zochio GP; Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1561-1568. PubMed ID: 31363805
[TBL] [Abstract][Full Text] [Related]
3. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
Lu S; Gao Y; Huang X; Wang X
Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen sulfide donors prevent lipopolysaccharide-induced airway hyperreactivity in an in vitro model of chronic inflammation in mice.
Karaman Y; Kaya-Yasar Y; Bozkurt TE; Sahin-Erdemli I
Basic Clin Pharmacol Toxicol; 2021 May; 128(5):652-660. PubMed ID: 33369105
[TBL] [Abstract][Full Text] [Related]
5. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
[TBL] [Abstract][Full Text] [Related]
6. GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat.
Li L; Salto-Tellez M; Tan CH; Whiteman M; Moore PK
Free Radic Biol Med; 2009 Jul; 47(1):103-13. PubMed ID: 19375498
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide.
Li L; Whiteman M; Guan YY; Neo KL; Cheng Y; Lee SW; Zhao Y; Baskar R; Tan CH; Moore PK
Circulation; 2008 May; 117(18):2351-60. PubMed ID: 18443240
[TBL] [Abstract][Full Text] [Related]
8. Biological Effects of Morpholin-4-Ium 4 Methoxyphenyl (Morpholino) Phosphinodithioate and Other Phosphorothioate-Based Hydrogen Sulfide Donors.
Nin DS; Idres SB; Song ZJ; Moore PK; Deng LW
Antioxid Redox Signal; 2020 Jan; 32(2):145-158. PubMed ID: 31642346
[No Abstract] [Full Text] [Related]
9. GYY4137, a novel water-soluble, H2S-releasing molecule.
Rose P; Dymock BW; Moore PK
Methods Enzymol; 2015; 554():143-67. PubMed ID: 25725521
[TBL] [Abstract][Full Text] [Related]
10. H
Yurinskaya MM; Krasnov GS; Kulikova DA; Zatsepina OG; Vinokurov MG; Chuvakova LN; Rezvykh AP; Funikov SY; Morozov AV; Evgen'ev MB
Inflamm Res; 2020 May; 69(5):481-495. PubMed ID: 32157318
[TBL] [Abstract][Full Text] [Related]
11. Phosphinodithioate and Phosphoramidodithioate Hydrogen Sulfide Donors.
Whiteman M; Perry A; Zhou Z; Bucci M; Papapetropoulos A; Cirino G; Wood ME
Handb Exp Pharmacol; 2015; 230():337-63. PubMed ID: 26162843
[TBL] [Abstract][Full Text] [Related]
12. Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance.
Lee ZW; Teo XY; Tay EY; Tan CH; Hagen T; Moore PK; Deng LW
Br J Pharmacol; 2014 Sep; 171(18):4322-36. PubMed ID: 24827113
[TBL] [Abstract][Full Text] [Related]
13. The route and timing of hydrogen sulfide therapy critically impacts intestinal recovery following ischemia and reperfusion injury.
Jensen AR; Drucker NA; Te Winkel JP; Ferkowicz MJ; Markel TA
J Pediatr Surg; 2018 Jun; 53(6):1111-1117. PubMed ID: 29622397
[TBL] [Abstract][Full Text] [Related]
14. GYY4137 alleviates sepsis-induced acute lung injury in mice by inhibiting the PDGFRβ/Akt/NF-κB/NLRP3 pathway.
Li J; Ma J; Li M; Tao J; Chen J; Yao C; Yao S
Life Sci; 2021 Apr; 271():119192. PubMed ID: 33577850
[TBL] [Abstract][Full Text] [Related]
15. [Effect of synthesized GYY4137, a slowly releasing hydrogen sulfide donor, on cell viability and distribution of hydrogen sulfide in mice].
Yu F; Zhao J; Tang CS; Geng B
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 42(5):493-7. PubMed ID: 20957002
[TBL] [Abstract][Full Text] [Related]
16. Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.
Druzhyna N; Szczesny B; Olah G; Módis K; Asimakopoulou A; Pavlidou A; Szoleczky P; Gerö D; Yanagi K; Törö G; López-García I; Myrianthopoulos V; Mikros E; Zatarain JR; Chao C; Papapetropoulos A; Hellmich MR; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):18-37. PubMed ID: 27521834
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen Sulfide Donor GYY4137 Acts Through Endothelial Nitric Oxide to Protect Intestine in Murine Models of Necrotizing Enterocolitis and Intestinal Ischemia.
Drucker NA; Jensen AR; Te Winkel JP; Markel TA
J Surg Res; 2019 Feb; 234():294-302. PubMed ID: 30527488
[TBL] [Abstract][Full Text] [Related]
18. GYY4137, an Extended-Release Hydrogen Sulfide Donor, Reduces NMDA-Induced Neuronal Injury in the Murine Retina.
Sone K; Mori A; Sakamoto K; Nakahara T
Biol Pharm Bull; 2018; 41(4):657-660. PubMed ID: 29607941
[TBL] [Abstract][Full Text] [Related]
19. A new slow releasing, H₂S generating compound, GYY4137 relaxes spontaneous and oxytocin-stimulated contractions of human and rat pregnant myometrium.
Robinson H; Wray S
PLoS One; 2012; 7(9):e46278. PubMed ID: 23029460
[TBL] [Abstract][Full Text] [Related]
20. Investigation of hydrogen sulfide gas as a treatment against P. falciparum, murine cerebral malaria, and the importance of thiolation state in the development of cerebral malaria.
DellaValle B; Staalsoe T; Kurtzhals JA; Hempel C
PLoS One; 2013; 8(3):e59271. PubMed ID: 23555646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
